Clarify’s medical devices are revolutionizing treatment for patients with psoriasis, eczema, and vitiligo. The devices help patients bypass painful and expensive hospital treatments with at-home alternatives. Clarify’s inventive, handheld device lets these patients self-treat using ultraviolet light therapy. But Clarify’s investors needed proof that patients were interested. In turn, Clarify needed a product launch for when FDA approval was met.